BTIG Reaffirms I-Mab - Depositary Receipt Buy Recommendation with 62.64% Upside Potential

BTIG reiterated its "Buy" recommendation for I-Mab - Depositary Receipt (IMAB) with a price target of $7.14/share, representing a 62.64% upside from its latest closing price of $4.39/share. The projected annual revenue for IMAB is $160MM, an increase of 28,065.08%. There are 44 funds or institutions reporting positions in IMAB, with an average portfolio weight of 0.06%.